Acadian Asset Management LLC 10x Genomics, Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$134.22 - $202.37 $23,891 - $36,021	-178 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$140.25 - $196.86 $169,422 - $237,806	-1,208 Reduced 87.16%	178 $32,000
Q4 2020 Feb 11, 2021	BUY	$126.47 - $163.7 $175,287 - $226,888	1,386 New	1,386 $197,000
Q3 2020 Nov 09, 2020	SELL	$87.44 - $125.0 $34,014 - $48,625	-389 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$58.39 - $89.31 $22,713 - $34,741	389 New	389 $35,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.